Patent · US Expired

Transgenic animals deficient in endogenous .beta..sub.3 -adrenergic receptor and uses thereof

US5789654A · kind A · utility

15Cited by

1References

13Claims

0Family size

Assignees

Beth Israel Hospital Association · US
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Bradford B. Lowell · Southborough, US
A. Donny Strosberg · Paris, FR

Key dates

Filing date	May 9, 1996
Grant date	Aug 4, 1998
Priority date	—
Expiry date	May 9, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed a transgenic non-human mammal whose germ cells and somatic cells contain a knockout mutation in DNA encoding .beta..sub.3 -adrenergic receptor polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.